These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
583 related items for PubMed ID: 16434056
1. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors. Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S. J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056 [Abstract] [Full Text] [Related]
2. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. Eklundh T, Eriksson M, Sjöberg S, Nordin C. J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658 [Abstract] [Full Text] [Related]
3. Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites. Nilsson-Todd LK, Nordin C, Jönsson EG, Skogh E, Erhardt S. Acta Neuropsychiatr; 2007 Feb; 19(1):45-52. PubMed ID: 26952797 [Abstract] [Full Text] [Related]
4. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system. González-Quevedo A, García JC, Fernández R, Fernández Cartaya L. Bol Estud Med Biol; 1993 Feb; 41(1-4):13-9. PubMed ID: 7521168 [Abstract] [Full Text] [Related]
5. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection]. Yoshino K. No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264 [Abstract] [Full Text] [Related]
6. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis. Andersen O, Johansson BB, Svennerholm L. Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303 [Abstract] [Full Text] [Related]
7. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid. Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR. Biol Psychiatry; 2004 Apr 01; 55(7):739-44. PubMed ID: 15039003 [Abstract] [Full Text] [Related]
8. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure. Eklundh T, Gunnarsson T, Ornhagen H, Nordin C. Aviat Space Environ Med; 2000 Nov 01; 71(11):1131-6. PubMed ID: 11086668 [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Eriksson E, Alling C, Andersch B, Andersson K, Berggren U. Neuropsychopharmacology; 1994 Nov 01; 11(3):201-13. PubMed ID: 7532413 [Abstract] [Full Text] [Related]
10. A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index. Ducci F, Newman TK, Funt S, Brown GL, Virkkunen M, Goldman D. Mol Psychiatry; 2006 Sep 01; 11(9):858-66. PubMed ID: 16770335 [Abstract] [Full Text] [Related]
11. Characterization of cerebrospinal fluid monoamine metabolites in peripubertal chimpanzees (Pan troglodytes). Fontenot MB, Musso MW, Watson SL, Anderson GM. J Med Primatol; 2010 Feb 01; 39(1):24-31. PubMed ID: 19843204 [Abstract] [Full Text] [Related]
12. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome. Kay AD, Schapiro MB, Riker AK, Haxby JV, Rapoport SI, Cutler NR. Ann Neurol; 1987 Apr 01; 21(4):408-11. PubMed ID: 2437853 [Abstract] [Full Text] [Related]
13. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S. Biol Psychiatry; 1983 Oct 01; 18(10):1141-52. PubMed ID: 6197099 [Abstract] [Full Text] [Related]
14. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Alfredsson G, Wiesel FA, Tylec A. Biol Psychiatry; 1988 Apr 01; 23(7):689-97. PubMed ID: 2453224 [Abstract] [Full Text] [Related]
15. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age. Blennow K, Wallin A, Gottfries CG, Karlsson I, Månsson JE, Skoog I, Wikkelsö C, Svennerholm L. Eur Neuropsychopharmacol; 1993 Mar 01; 3(1):55-61. PubMed ID: 7682460 [Abstract] [Full Text] [Related]
16. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid. Vaughn DM, Coleman E, Simpson ST, Satjawatcharaphong C. Am J Vet Res; 1988 Aug 01; 49(8):1302-6. PubMed ID: 2459997 [Abstract] [Full Text] [Related]
17. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers. Nordin C, Eklundh T, Fernström V, Swedin A, Zachau AC. J Psychiatr Res; 1995 Aug 01; 29(2):133-40. PubMed ID: 7545235 [Abstract] [Full Text] [Related]
18. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. Blennow K, Wallin A, Gottfries CG, Månsson JE, Svennerholm L. J Neural Transm Park Dis Dement Sect; 1993 Aug 01; 5(1):5-15. PubMed ID: 7679905 [Abstract] [Full Text] [Related]
19. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers. Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. Eur Neuropsychopharmacol; 2011 Sep 01; 21(9):700-4. PubMed ID: 21295953 [Abstract] [Full Text] [Related]
20. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients. Nordin C. Acta Psychiatr Scand; 1988 Dec 01; 78(6):720-9. PubMed ID: 2464903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]